NEW YORK, Sept 9 (Reuters) – Private equity firm TPG is exploring the sale of Lyric, in a process that could value the software company which supports payments in the healthcare industry at about $5
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)